(NYSE: COR) Cencora's forecast annual revenue growth rate of 7.28% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.87%.
Cencora's revenue in 2024 is $293,958,599,000.On average, 6 Wall Street analysts forecast COR's revenue for 2025 to be $61,284,715,362,961, with the lowest COR revenue forecast at $60,846,250,281,204, and the highest COR revenue forecast at $61,642,931,690,270. On average, 6 Wall Street analysts forecast COR's revenue for 2026 to be $65,578,937,167,825, with the lowest COR revenue forecast at $64,443,035,390,169, and the highest COR revenue forecast at $67,117,127,783,434.
In 2027, COR is forecast to generate $70,217,762,966,299 in revenue, with the lowest revenue forecast at $67,665,220,587,478 and the highest revenue forecast at $72,145,523,233,688.